2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
2
Hot Flashes
2
Carcinoma, Intraductal, Noninfiltrating
1
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
1
Interventions
Tamoxifen
25
Radiotherapy
15
Chemotherapy, Adjuvant
11
Anastrozole
11
Specimen Handling
10
Neoadjuvant Therapy
8
Letrozole
8
Biopsy
7
Radiation
6
Mastectomy, Segmental
6
Magnetic Resonance Spectroscopy
6
Immunohistochemistry
5
Gene Expression Profiling
5
exemestane
4
Surgical Procedures, Operative
4
Sentinel Lymph Node Biopsy
4
Radiotherapy, Intensity-Modulated
4
Radiotherapy, Conformal
4
Psychiatric Rehabilitation
4
Mass Spectrometry
4
Early Intervention, Educational
4
Counseling
4
afimoxifene
3
Trastuzumab
3
Surveys and Questionnaires
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation Dose Hypofractionation
3
Methods
3
Mastectomy
3
High-Energy Shock Waves
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
fezolinetant
×
Clear all
NCT06617455
2026-05-06
VEnT
University of Michigan Rogel Cancer Center
Phase 2
Terminated
9 enrolled